Shares of Kroger (NYSE: KR) rallied nearly 30% over the past 12 months as the S&P 500 advanced less than 10%. The largest supermarket operator in America dazzled the market with its robust sales growth, its resistance to macro headwinds, and its effective digital strategies. It also ramped up its buybacks after its planned merger with Albertsons (NYSE: ACI) collapsed.But can Kroger’s stock keep climbing higher over the next 12 months as tariffs, trade wars, and other unpredictable headwinds rattle the economy? Let’s dig deeper to find out.Image source: Getty Images.Continue readinghttps://www.fool.com/investing/2025/05/01/where-will-kroger-stock-be-in-1-year/
Beat the Nasdaq With This Cash-Gushing Dividend Stock
May 1, 2025
Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence. Biotech giant Amgen (NASDAQ: AMGN) exemplifies this strategy with its 3.3% dividend yield, supported by steady growth and rock-solid fundamentals. Compared to an 8% decline in the Nasdaq Composite index year to date, Amgen stock has outperformed, up 9% thus far in 2025.Let’s explore why this cash-generating healthcare leader is well-positioned to continue beating the Nasdaq.The biopharmaceutical industry is one of the most vital sectors in the economy, developing groundbreaking medicines that can be life-changing for patients fighting serious diseases. Amgen stands out with a highly diversified portfolio of over 40 therapeutics across four key areas — General Medicine, Rare Disease, Inflammation, and Oncology. Notably, 14 of its products have achieved blockbuster status, generating over $1 billion in annualized sales with best-in-class profiles.Continue readinghttps://www.fool.com/investing/2025/05/01/beat-the-nasdaq-with-this-cash-gushing-dividend/
